Semaglutide 2.4 mg ‘likely to usher in a new era’ in obesity treatmentJune 29, 2021DiabetesLipid DisordersObesity
Maintain OMT for 5 years after revascularization, boost survival at 10 years: SYNTAXESJune 29, 2021Lipid Disorders
SUSTAIN FORTE: Higher-dose semaglutide safely boosts glycemic control, weight lossJune 27, 2021DiabetesLipid DisordersObesity
‘Stunning’ twincretin beats semaglutide for A1c, weight reduction in T2DJune 26, 2021DiabetesLipid DisordersObesity
Time-restricted eating ‘promising, but more data are needed’June 26, 2021ObesityLipid DisordersDiabetes
Stopping statins linked to death, CV events in elderlyJune 25, 2021HypertensionLipid DisordersDiabetes
No overall statin effect seen on dementia, cognition in ASPREE analysisJune 23, 2021Lipid DisordersDiabetesObesity
Bariatric surgery tied to 22% lower 5-year stroke riskJune 18, 2021ObesityHypertensionLipid Disorders
Medically suspect criterion can determine bariatric surgery coverageJune 18, 2021ObesityHypertensionLipid DisordersBusiness of Medicine
Bariatric surgery cuts insulin needs in type 1 diabetes with severe obesityJune 17, 2021DiabetesObesityLipid Disorders
Healthy with obesity? The latest study casts doubtJune 16, 2021ObesityLipid DisordersDiabetesHypertension
Bariatric surgery tied to fewer HFpEF hospitalizationsJune 15, 2021ObesityLipid DisordersHypertension
